Although allergic asthma has always been considered to be a Th2 disease with increased eosinophils and Th2 cytokines such as IL-4, IL-5 and IL-13, severe asthma related to clinical resistance may result from a mixed Th2/Th17 response [35]. This evidence concerns the gene IL13 and asthma.